Background While transcatheter device closure of ventricular septal defects (VSDs) is
gaining popularity, concerns remain about adverse events; particularly heart block in peri …

Interventional closure of congenital ventricular septal defects (VSD) is recording a
continuous rise in acceptance. Complete atrioventricular block (cAVB) and residual shunting …

Background: Off-label device closure of perimembranous ventricular septal defect (pmVSD)
is well reported in the literature with encouraging results. However, technical challenges …

Objectives. To demonstrate safety and efficacy of using different generations of softer
Amplatzer™ devices for ventricular septal defect (VSD) closure to avoid serious …

Objective To evaluate the efficacy and safety of Nit‐Occlud Lê VSD Coil versus Duct
Occluders for percutaneous closure of perimembranous ventricular septal defect (pmVSD) …

Background: Ventricular septal defect (VSD) is one of the most common congenital heart
defects. Currently, surgery remains the treatment of choice. However, transcatheter …

Objective This study presents data from the admission trial to show the feasibility, safety and
effectiveness of the Nit-Occlud® Lê VSD in the treatment of perimembranous ventricular …

Objectives To assess the safety and efficacy of percutaneous closure of perimembranous
ventricular septal defect (PmVSD) using patent ductus arteriosus (PDA) occluders …

Long term follow up studies have shown that transcatheter closure of perimembranous
Ventricular Septal Defect (PmVSD) can be done safely and successfully. One of the most …

Abstract Transcatheter closure of Perimembranous VSDs (PMVSD) remains challenging
particularly in infants. The aim of this study is to evaluate the efficacy and safety of …